← All trials
NCT06530849
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 22, 2024
- Primary completion
- Feb 28, 2027
- Completion date
- Feb 28, 2027
- First posted
- Jul 31, 2024
- Last posted
- Nov 4, 2024
- Enrollment
- 118
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Gracell Biotechnology Ltd.Lead sponsor
- AstraZenecaCollaborator
- Gracell Biotechnology Ltd.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.